CD44 and neoplasm: Our previous research had demonstrated that lysates of CD44+ CSCs derived from CT-26 colon cancer cell lines may be a possible source of tumor antigens to pulse DCs 10, in that they evoked potent tumor-specific CTL activity against colon cancer model in vivo and killed the CT-26 cancer stem cells in vitro.